etidronate and furosemide

etidronate has been researched along with furosemide in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Charles, P; Hasling, C; Mosekilde, L1
Güliter, S; Keleş, H; Keleş, I; Ozkurt, ZN1
Nammalwar, BR; Prahlad, N; Shanmughasundharam, R; Vijayakumar, M1

Reviews

1 review(s) available for etidronate and furosemide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for etidronate and furosemide

ArticleYear
Etidronate disodium for treating hypercalcaemia of malignancy: a double blind, placebo-controlled study.
    European journal of clinical investigation, 1986, Volume: 16, Issue:5

    Topics: Adult; Aged; Calcium; Clinical Trials as Topic; Double-Blind Method; Etidronic Acid; Female; Furosemide; Humans; Hypercalcemia; Infusions, Intravenous; Male; Middle Aged; Neoplasms

1986

Other Studies

6 other study(ies) available for etidronate and furosemide

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Risedronate-induced intravascular haemolysis complicated by acute tubular necrosis.
    Clinical rheumatology, 2005, Volume: 24, Issue:6

    Topics: Bone Density Conservation Agents; Calcium; Etidronic Acid; Female; Furosemide; Hemolysis; Humans; Isotonic Solutions; Kidney Tubular Necrosis, Acute; Middle Aged; Risedronic Acid; Sodium Chloride; Treatment Outcome

2005
Subcutaneous fat necrosis with hypercalcemia.
    Indian pediatrics, 2006, Volume: 43, Issue:4

    Topics: Administration, Oral; Bone Density Conservation Agents; Calcium; Diuretics; Etidronic Acid; Fat Necrosis; Furosemide; Glucocorticoids; Humans; Hypercalcemia; Infant, Newborn; Infusions, Intravenous; Nephrocalcinosis; Potassium Citrate; Prednisolone; Sodium Chloride

2006